Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Farmers Insurance
Citi
Medtronic
QuintilesIMS
Dow
Fuji
US Department of Justice
Cantor Fitzgerald
Chinese Patent Office

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 207938

« Back to Dashboard

NDA 207938 describes PIROXICAM, which is a drug marketed by Cycle Pharms Ltd, Egis, Flamingo Pharms, Hikma Pharms, Ivax Sub Teva Pharms, Mylan, Mylan Ireland Ltd, PII, SCS, Sun Pharm Industries, Teva, Teva Pharms, Unichem Labs Ltd, and Watson Labs, and is included in nineteen NDAs. It is available from twenty-three suppliers. Additional details are available on the PIROXICAM profile page.

The generic ingredient in PIROXICAM is piroxicam. There are sixteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the piroxicam profile page.
Summary for 207938
Tradename:PIROXICAM
Applicant:Flamingo Pharms
Ingredient:piroxicam
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 207938
Medical Subject Heading (MeSH) Categories for 207938
Suppliers and Packaging for NDA: 207938
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PIROXICAM piroxicam CAPSULE;ORAL 207938 ANDA Northstar Rx LLC 16714-411 16714-411-01 100 CAPSULE in 1 BOTTLE (16714-411-01)
PIROXICAM piroxicam CAPSULE;ORAL 207938 ANDA Northstar Rx LLC 16714-412 16714-412-02 500 CAPSULE in 1 BOTTLE (16714-412-02)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength10MG
Approval Date:Sep 9, 2016TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength20MG
Approval Date:Sep 9, 2016TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
US Department of Justice
Cipla
Queensland Health
Healthtrust
Argus Health
Johnson and Johnson
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot